Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Biopharm Drug Dispos. 2011 Sep 22;32(8):471–481. doi: 10.1002/bdd.770

Table V.

Ibandronate pharmacodynamic parameter estimates for urine CTX in postmenopausal women with osteopenia, using integrated bone homeostasis model.

Parameter (units) Final Estimate CV%
DA (day−1) 0.842 15.2
Imax 1 a -
h 2 b -
IC50 (ng/L) 522 8.74
Eb,uCTX (μg/mmolCr) 31 28.7
n (dimensionless) 5 b -
a

fixed parameter based on indirect response model theory [22].

b

fixed parameter based on preliminary analysis.